AI, handheld imaging to drive ultrasound-on-chip market growth

It is expected to reach $200.5m by 2036.

The global ultrasound-on-chip licensing market is projected to grow to $200.5m by 2036, driven by rising demand for compact ultrasound systems, AI-powered diagnostics, and handheld imaging devices.

In a report, Future Market Insights said the market is anticipated to generate an absolute dollar opportunity of $150.5m between 2026 and 2036.

Increasing investments in AI-assisted diagnostics, semiconductor-based imaging technologies, and embedded ultrasound platforms also continue to strengthen commercial opportunities for the market.

The medical segment accounts for 72% of global market demand in 2026, driven by increasing adoption of portable ultrasound systems across emergency medicine, cardiology, critical care, obstetrics, and primary healthcare settings.

However, complex regulatory approval processes, intellectual property protection challenges, high technology development costs, integration complexity, and lengthy qualification cycles continue to pose challenges for market participants.

North America continues to lead market innovation, supported by strong medical device development, advanced healthcare infrastructure, and widespread adoption of AI-powered imaging technologies.

Asia-Pacific is expected to witness significant expansion as healthcare digitisation and local medical device manufacturing continue accelerating.

Meanwhile, China is projected to be the fastest-growing country, registering a 16.8% compound annual growth rate through 2036.